Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines).
The neurobiology of P300 is still a subject of controversy. P300 amplitude appears to be modulated by multiple neurotransmitter systems, especially dopaminergic, noradrenergic as well as cholinergic and GABAergic. In this study, we investigated the relationship between P300 amplitude and catecholaminergic neurotransmission as assessed by the growth hormone (GH) response to clonidine and apomorphine challenges in 20 major depressive patients. Results showed a correlation of P300 amplitude with the apomorphine test (r = 0.54; P = 0.01), but not with the clonidine test (r = 0.22; NS). This study supports a role for dopamine in the neurobiological modulation of P300 amplitude.
Hansenne
M
M
Psychiatric Unit, CHU du Sart Tilman, Liège, Belgium.
Pitchot
W
W
Gonzalez Moreno
A
A
Papart
P
P
Timsit-Berthier
M
M
Ansseau
M
M
D000328:Adult; D001058:Apomorphine; D001921:Brain / Q000503:physiopathology*; D002395:Catecholamines / Q000502:physiology*; D003000:Clonidine; D003866:Depressive Disorder / Q000097:blood / Q000503:physiopathology*; D004569:Electroencephalography; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged
D002395:Catecholamines; D013006:Growth Hormone; D003000:Clonidine; D001058:Apomorphine